The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer's disease.

Current Neurology and Neuroscience Reports
Joseph H LeeC Reitz

Abstract

Recent studies indicate that two clusters of single nucleotide polymorphisms in the neuronal sortilin-related receptor gene (SORL1) are causally associated with late-onset Alzheimer's disease (AD). At the cellular level, SORL1 is thought to be involved in intracellular trafficking of amyloid precursor protein. When this gene is suppressed, toxic amyloid beta production is increased, and high levels of amyloid betaare associated with a higher AD risk. Extending the cellular findings, gene expression studies show that SORL1 is differentially expressed in AD patients compared with controls. Furthermore, several genetic studies have identified allelic and haplotypic SORL1 variants associated with late-onset AD, and these variants confer small to modest risk of AD. Taken together, the evidence for SORL1 as a causative gene is compelling. However, putative variants have not yet been identified. Further research is necessary to determine its utility as a diagnostic marker of AD or as a target for new therapeutic approaches.

References

Apr 10, 1992·Science·J A Hardy, G A Higgins
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·N K RobakisH M Wisniewski
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
May 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
Aug 18, 1995·Science·E Levy-LahadG D Schellenberg
Apr 2, 2003·The American Journal of Psychiatry·Irving I Gottesman, Todd D Gould
Apr 8, 2003·Nature Cell Biology·Dieter EdbauerChristian Haass
Aug 18, 2004·Archives of Neurology·Clemens R ScherzerJames J Lah
Dec 24, 2004·The Journal of Biological Chemistry·Xiangyuan HeJordan Tang
May 7, 2005·American Journal of Human Genetics·Mingyao LiGoncalo R Abecasis
Jun 1, 2005·Biochimica Et Biophysica Acta·Linton M Traub
Jun 3, 2005·The Journal of Clinical Investigation·Lars Bertram, Rudolph E Tanzi
Sep 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Olav M AndersenThomas E Willnow
Nov 30, 2005·Annals of Neurology·Scott A SmallTae-Wan Kim
Feb 3, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Katrin OffeJames J Lah
Mar 15, 2006·Nature Reviews. Genetics·Ryan R BrinkmanMark E Samuels
May 16, 2006·Trends in Genetics : TIG·Carrie E Bearden, Nelson B Freimer
Sep 8, 2006·Journal of Neuropathology and Experimental Neurology·Sara E DodsonJames J Lah
Jan 16, 2007·Nature Genetics·Ekaterina RogaevaPeter St George-Hyslop
Jun 8, 2007·Neuron·Eric M ReimanDietrich A Stephan
Oct 24, 2007·Neurobiology of Disease·Yonghong LiAndrew Grupe
Nov 3, 2007·Neuro-degenerative Diseases·Jennifer A WebsterDietrich A Stephan
Dec 20, 2007·Neuroreport·Yan MengLindsay A Farrer

❮ Previous
Next ❯

Citations

Apr 17, 2012·International Journal of Alzheimer's Disease·Christiane Reitz
Mar 30, 2016·Alzheimer Disease and Associated Disorders·Jenny Ortega-RojasHumberto Arboleda
Dec 23, 2011·International Journal of Alzheimer's Disease·Paolo OlgiatiAlessandro Serretti
Oct 1, 2010·Neuroscience Bulletin·Jun-Feng WangYi-Zheng Wang
Nov 19, 2013·The Journal of Pharmacy and Pharmacology·Brígida R PinhoPaula B Andrade
Nov 9, 2016·Neurology. Genetics·Michael L CuccaroMargaret A Pericak-Vance
Nov 25, 2018·Journal of Clinical Medicine·Young-Kook Kim, Juhyun Song
Aug 15, 2012·Nature Reviews. Neurology·Johnathan Cooper-KnockPamela J Shaw
Jan 19, 2013·Current Atherosclerosis Reports·Christiane Reitz
Nov 11, 2014·Annals of Neurology·Badri N VardarajanRichard Mayeux
Sep 28, 2017·Reviews in the Neurosciences·Ahmed A MoustafaMichael Hornberger
Jan 20, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ying LiangZhanjun Zhang
Sep 11, 2020·Psychiatry and Clinical Neurosciences·Mei-Feng HuangJong-Ling Fuh
Sep 24, 2020·Journal of Neurochemistry·Melina OverhoffNatalia L Kononenko
Nov 2, 2016·Journal of Cell Science·Cinzia Progida, Oddmund Bakke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Related Papers

Archives of Neurology
C ReitzGenetic and Environmental Risk in Alzheimer Disease 1 Consortium
© 2022 Meta ULC. All rights reserved